143 related articles for article (PubMed ID: 31830018)
1. Barriers to the prescription of LARCs in general practice in New Zealand-a qualitative research study.
McGinn O; Fulcher HJ; Arroll B; McCowan L
N Z Med J; 2019 Dec; 132(1507):63-69. PubMed ID: 31830018
[TBL] [Abstract][Full Text] [Related]
2. 'We're kidding ourselves if we say that contraception is accessible': a qualitative study of general practitioners' attitudes towards adolescents' use of long-acting reversible contraceptives (LARC).
Duncan R; Paterson H; Anderson L; Pickering N
J Prim Health Care; 2019 Jul; 11(2):138-145. PubMed ID: 32171356
[TBL] [Abstract][Full Text] [Related]
3. A Qualitative Study of Prescription Contraception Use: The Perspectives of Users, General Practitioners and Pharmacists.
Sweeney LA; Molloy GJ; Byrne M; Murphy AW; Morgan K; Hughes CM; Ingham R
PLoS One; 2015; 10(12):e0144074. PubMed ID: 26633191
[TBL] [Abstract][Full Text] [Related]
4. Who can afford a Mirena® for contraception?
Murray C; Roke C
J Prim Health Care; 2018 Oct; 10(3):201-206. PubMed ID: 31039933
[TBL] [Abstract][Full Text] [Related]
5. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
Luo Z; Gao L; Anguzu R; Zhao J
Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
[TBL] [Abstract][Full Text] [Related]
6. Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners.
Nanda G; Rademacher K; Solomon M; Mercer S; Wawire J; Ngahu R
Eur J Contracept Reprod Health Care; 2018 Aug; 23(4):303-308. PubMed ID: 30198796
[TBL] [Abstract][Full Text] [Related]
7. LARCs as first-line contraception - What can general practitioners advise young women?
Temple-Smith M; Sanci L
Aust Fam Physician; 2017 Oct; 46(10):710-715. PubMed ID: 29036768
[TBL] [Abstract][Full Text] [Related]
8. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol.
Mazza D; Black K; Taft A; Lucke J; McGeechan K; Haas M; McKay H; Peipert JF
BMJ Open; 2016 Oct; 6(10):e012491. PubMed ID: 27855100
[TBL] [Abstract][Full Text] [Related]
9. Understanding barriers to using long-acting reversible contraceptives (LARCs) in primary care: a qualitative evidence synthesis.
Linton E; Mawson R; Hodges V; Mitchell CA
BMJ Sex Reprod Health; 2023 Oct; 49(4):282-292. PubMed ID: 36810206
[TBL] [Abstract][Full Text] [Related]
10. Can Pediatricians Provide Long-Acting Reversible Contraception?
Norris AH; Pritt NM; Berlan ED
J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):39-43. PubMed ID: 30278228
[TBL] [Abstract][Full Text] [Related]
11. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
12. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
Matusiewicz AK; Melbostad HS; Heil SH
Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
[TBL] [Abstract][Full Text] [Related]
13. Expanding Access to a New, More Affordable Levonorgestrel Intrauterine System in Kenya: Service Delivery Costs Compared With Other Contraceptive Methods and Perspectives of Key Opinion Leaders.
Rademacher KH; Solomon M; Brett T; Bratt JH; Pascual C; Njunguru J; Steiner MJ
Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S83-93. PubMed ID: 27540128
[TBL] [Abstract][Full Text] [Related]
14. Sustainable and effective methods to increase long-acting reversible contraception uptake from the ACCORd general practice trial.
Taft A; Watson CJ; McCarthy E; Black KI; Lucke J; McGeechan K; Haas M; McNamee K; Peipert JF; Mazza D
Aust N Z J Public Health; 2022 Aug; 46(4):540-544. PubMed ID: 35557481
[TBL] [Abstract][Full Text] [Related]
15. Attitudes toward long-acting reversible contraception among young women seeking abortion.
Rose SB; Cooper AJ; Baker NK; Lawton B
J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
[TBL] [Abstract][Full Text] [Related]
16. Vouchers in Fragile States: Reducing Barriers to Long-Acting Reversible Contraception in Yemen and Pakistan.
Boddam-Whetham L; Gul X; Al-Kobati E; Gorter AC
Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S94-S108. PubMed ID: 27540129
[TBL] [Abstract][Full Text] [Related]
17. Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon.
Ajong AB; Njotang PN; Kenfack B; Essi MJ; Yakum MN; Iballa FBS; Mbu ER
PLoS One; 2018; 13(8):e0202967. PubMed ID: 30138474
[TBL] [Abstract][Full Text] [Related]
18. A Qualitative Study of Factors That Influence Contraceptive Choice among Adolescent School-Based Health Center Patients.
Hoopes AJ; Gilmore K; Cady J; Akers AY; Ahrens KR
J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):259-64. PubMed ID: 26477942
[TBL] [Abstract][Full Text] [Related]
19. Views of general practitioners on providing contraceptive advice and long-acting reversible contraception at the 6-week postnatal visit: a qualitative study.
Lunniss H; Cameron S; Chen ZE
J Fam Plann Reprod Health Care; 2016 Apr; 42(2):99-106. PubMed ID: 26311649
[TBL] [Abstract][Full Text] [Related]
20. Reviewing the cost-effectiveness of long-acting reversible contraceptive methods in an Australian context.
Lynch M; De Abreu Lourenco R; Flattery M; Haas M
Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):21-35. PubMed ID: 30311634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
